The intelligence graph connecting private capital, companies and real assets. Public records ingested on their own cadence, resolved to one identity by shared identifier, connected by typed relationships with a date and a source on every edge, and read by detectors that say what changed and what it means. Facts, derived metrics, signals, anomalies and inferences are labelled as such.
Reading the graph
Venture Capital
Saint Louis, MO
Data as of (this record's last observation) from federal regulator filings. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Acm-Oct Convertible Note Partnership | 2024 | EARLY DEPLOYMENT | n/a | $338,000 | 0 |
| Acm-Intershunt Convertible Note and Series B | 2024 | EARLY DEPLOYMENT | n/a | $569,000 | 0 |
| Acm-Ideate Medical Partnership Tranche 5 | 2024 | EARLY DEPLOYMENT | n/a | $470,280 | 0 |
| Acm-Kypha Convertible Note | 2024 | EARLY DEPLOYMENT | n/a | $1.7M | 0 |
| Acm-Kypha Series B | 2024 | EARLY DEPLOYMENT | n/a | $253,000 | 0 |
| ACM- Aptimmune Convertible Note Partnership | 2023 | ACTIVE DEPLOYMENT | n/a | $815,000 | 0 |
| Acm-Common Place Holdings | 2023 | ACTIVE DEPLOYMENT | n/a | $2.0M | 0 |
| Acm-Intershunt Technologies Series a Preferred | 2023 | ACTIVE DEPLOYMENT | n/a | $115,000 | 0 |
| Acm-Harbor Medtech Series B Preferred | 2023 | ACTIVE DEPLOYMENT | n/a | $4.5M | 0 |
| Acm-Deck Commerce Convertible Note | 2023 | WOUND DOWN | n/a | $2.9M | 0 |
| Acm-Juristat Series A-4 | 2023 | ACTIVE DEPLOYMENT | n/a | $1.5M | 0 |
| ACM- Bonfyre Series A-1 | 2023 | ACTIVE DEPLOYMENT | n/a | $5.6M | 0 |
| Bonfyre Series a | 2023 | ACTIVE DEPLOYMENT | n/a | $750,000 | 0 |
| Acm-Ideate Medical Part Tranche 2 | 2023 | ACTIVE DEPLOYMENT | n/a | $689,385 | 0 |
| Acm-Deck Commerce Seed Preferred | 2023 | WOUND DOWN | n/a | $3.3M | 0 |
| Acm-Deck Commerce A-2 Partnership | 2023 | WOUND DOWN | n/a | $333,000 | 0 |
| Acm-Ideate Medical Part Tranche 3 | 2023 | ACTIVE DEPLOYMENT | n/a | $1.3M | 0 |
| Acm-Wellopp Convertible Note | 2023 | ACTIVE DEPLOYMENT | n/a | $348,000 | 0 |
| Acm-Kypha Series B-1 | 2023 | ACTIVE DEPLOYMENT | n/a | $2.1M | 0 |
| Acm-Juristat A5 | 2023 | ACTIVE DEPLOYMENT | n/a | $2.4M | 0 |
| Acm-Wellopp Series B-1 Partnership | 2023 | ACTIVE DEPLOYMENT | n/a | $323,750 | 0 |
| Acm-Juristat Convertible Note | 2023 | ACTIVE DEPLOYMENT | n/a | $667,300 | 0 |
| Acm-Kypha Series Seed Partnership | 2023 | ACTIVE DEPLOYMENT | n/a | $6.6M | 0 |
| Acm-Aptimmune Series a | 2023 | ACTIVE DEPLOYMENT | n/a | $2.7M | 0 |
| ACM- Bonfyre Series A-2 | 2023 | ACTIVE DEPLOYMENT | n/a | $2.2M | 0 |
Also named here, with no published line of their own (reach them through the firm): Peter Frederick Reinecke (Manager).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan